Art

J-GLOBAL ID：202202263323540933   Reference number：22A1029213

Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis

肺結核治療患者における活動性結核のCT特徴および最終治療FDG PET/CTにおける残存代謝活性との相関【JST・京大機械翻訳】

Author (15)： Lawal Ismaheel O. (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) ,  Lawal Ismaheel O. (Nuclear Medicine Research Infrastructure, Steve Biko Academic Hospital, Pretoria, South Africa) ,  Mokoala Kgomotso M. G. (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) ,  Mokoala Kgomotso M. G. (Nuclear Medicine Research Infrastructure, Steve Biko Academic Hospital, Pretoria, South Africa) ,  Mathebula Matsontso (Department of Medical Microbiology and MeCRU, Sefako Makgatho University of Medical Science, Pretoria, South Africa) ,  Moagi Ingrid (Department of Medical Microbiology and MeCRU, Sefako Makgatho University of Medical Science, Pretoria, South Africa) ,  Popoola Gbenga O. (Department of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria) ,  Moeketsi Nontando (Department of Medical Microbiology and MeCRU, Sefako Makgatho University of Medical Science, Pretoria, South Africa) ,  Nchabeleng Maphoshane (Department of Medical Microbiology and MeCRU, Sefako Makgatho University of Medical Science, Pretoria, South Africa) ,  Hikuam Chris (South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Division of Immunology, University of Cape Town, Cape Town, South Africa) ,  Ellner Jerrold J. (Department of Medicine, Centre for Emerging Pathogens, Rutgers-New Jersey Medical School, Newark, NJ, United States) ,  Hatherill Mark (South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Division of Immunology, University of Cape Town, Cape Town, South Africa) ,  Fourie Bernard P. (Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa) ,  Sathekge Mike M. (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) ,  Sathekge Mike M. (Nuclear Medicine Research Infrastructure, Steve Biko Academic Hospital, Pretoria, South Africa)
Material： Frontiers in Medicine (Web)
Volume： 9  Page： 791653  Publication year： 2022 
JST Material Number： U7079A  ISSN： 2296-858X  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Patients who complete a standa...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1029213&from=J-GLOBAL&jstjournalNo=U7079A") }}

Thesaurus term： *tuberculosis ,  image processing ,  availability ,  image ,  *pulmonary tuberculosis ,  pleural effusion ,  lung disease ,  PET(tomography) ,  computed tomography ,  HIV infection
Semi thesaurus term： モダリティ ,  *FDG PET ,  *PET/CT ,  治療反応性 ,  *FDG-PET/CT ,  肺結節 , 【Automatic Indexing@JST】

Author keywords (6)： pulmonary tuberculosis ,  end-of-treatment ,  FDG PET/CT ,  residual metabolic activity ,  computed tomography ,  HIV infection

JST classification (2)： Diagnostics of infectious diseases,parasitic diseases.  (GD01020S) ,  Radiodiagnosis  (GC04020K)

Reference (27)：

• Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. (2016) 63:e147-95. doi: 10.1093/cid/ciw376
• Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, et al. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis. N Engl J Med. (2021) 384:1705-18. doi: 10.1056/NEJMoa2033400
• Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, et al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med. (2014) 371:1577-87. doi: 10.1056/NEJMoa1407426
• Velayutham B, Jawahar MS, Nair D, Nevaneethapandian P, Ponnuraja C, Chandrasekaran K, et al. 4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomsied clinical trial. Trop Med Int Health. (2020) 25:483-95. doi: 10.1111/tmi.13371
• Grace AG, Mittal A, Jain S, Tripathy JP, Satyanarayana S, Tharyan P, et al. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis. Cochrane Database Syst Rev. (2019) 12:CD012918. doi: 10.1002/14651858.CD012918.pub2

Terms in the title (10)： 肺結核 ,  治療 ,  患者 ,  活動性結核 ,  CT ,  FDG ,  PET ,  残存 ,  代謝活性 ,  相関